Emerging therapeutic advances for immune thrombocytopenia: highlights from selected early‑phase and pivotal trials at the 2025 ASH annual meeting. [PDF]
Exp Hematol OncolCao L, Wang Z, Xiang Q.
europepmc +1 more source
Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort Study
American Journal of Hematology, Volume 101, Issue 9, Page 2123-2136, September 2026.ABSTRACT Cancer care is often complicated by coagulopathy leading to thrombosis and bleeding. While venous thromboembolism (VTE) has been extensively studied, bleeding remains an underestimated threat. To address this knowledge gap, we leveraged the Epic Cosmos database to determine the impact of cancer‐associated clinically relevant bleeding (CRB) in ...
Ming Y. Lim +11 more
wiley +1 more source
A novel ELF4 gene variant disrupts T and NK cell function in a patient with immune thrombocytopenia (ITP). [PDF]
Inflamm ResKendirli PK +9 more
europepmc +1 more source
Haemostasis alterations in immune thrombocytopenia and their clinical significance. [PDF]
Res Pract Thromb HaemostPincez T, Mathews N, Bonnefoy A.
europepmc +1 more source
Bernard Soulier Syndrome Misdiagnosed and Treated as Immune Thrombocytopenia Purpura: A Case Report. [PDF]
CureusJannat M +4 more
europepmc +1 more source
Platelet Satellitism Causing Apparent Loss of Response to Eltrombopag in a Patient With Immune Thrombocytopenia. [PDF]
Int J Lab HematolEbeling T +3 more
europepmc +1 more source
Zonulin levels in children with chronic immune thrombocytopenia. [PDF]
Medicine (Baltimore)Karadoğan M +4 more
europepmc +1 more source
Successful Management of Relapsed Severe Immune Thrombocytopenia Using Avatrombopag: A Case Report. [PDF]
Case Rep HematolAlmutairi S +7 more
europepmc +1 more source